Related Experiment Videos

Prolactin response to morphine in depression

Psychiatry Research
|April 1, 1984
PubMed

Insights

Major depressive disorder patients showed a significantly lower prolactin response to morphine sulfate compared to healthy individuals. This suggests potential neuroendocrine abnormalities in depression.

Area of Science:

  • Neuroendocrinology
  • Psychiatry
  • Pharmacology

Background:

  • Major depressive disorder (MDD) is a complex mental health condition.
  • Neurotransmitter systems, including dopamine and serotonin, are implicated in MDD.
  • Anterior pituitary function may be altered in psychiatric disorders.

Purpose of the Study:

  • To investigate the prolactin response to morphine sulfate in unmedicated patients with MDD.
  • To compare prolactin levels in MDD patients with healthy controls and patients with other psychiatric diagnoses.

Main Methods:

  • Administration of morphine sulfate (5 mg, i.v.) to participants.
  • Measurement of serum prolactin levels.
  • Comparison of maximum prolactin response among groups: MDD inpatients, normal controls, and other psychiatric inpatients.

Main Results:

  • Mean maximum prolactin response was significantly lower in MDD patients compared to normal controls and other psychiatric patients.
  • 8 out of 15 MDD patients exhibited a prolactin response lower than the lowest response in normal controls.
  • Six MDD patients showed blunted prolactin responses (< 2 ng/ml) at 60 minutes.

Conclusions:

  • Diminished prolactin increase after morphine in MDD patients may indicate anterior pituitary dysfunction.
  • Potential neuroregulatory system abnormalities (opioid, dopamine, serotonin) are suggested in MDD.
  • These findings highlight potential neuroendocrine alterations in the pathophysiology of major depressive disorder.

Related Concept Videos